Annual Cash & Cash Equivalents
$106.28 M
-$10.04 M-8.63%
31 December 2023
Summary:
Health Catalyst annual cash & cash equivalents is currently $106.28 million, with the most recent change of -$10.04 million (-8.63%) on 31 December 2023. During the last 3 years, it has risen by +$14.32 million (+15.58%). HCAT annual cash & cash equivalents is now -45.00% below its all-time high of $193.23 million, reached on 31 December 2021.HCAT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$328.33 M
+$126.43 M+62.62%
30 September 2024
Summary:
Health Catalyst quarterly cash and cash equivalents is currently $328.33 million, with the most recent change of +$126.43 million (+62.62%) on 30 September 2024. Over the past year, it has increased by +$233.36 million (+245.71%). HCAT quarterly cash and cash equivalents is now at all-time high.HCAT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HCAT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.6% | +245.7% |
| 3 y3 years | +15.6% | +19.1% |
| 5 y5 years | +273.8% | +530.7% |
HCAT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.0% | +15.6% | at high | +245.7% |
| 5 y | 5 years | -45.0% | +489.4% | at high | +1720.8% |
| alltime | all time | -45.0% | +489.4% | at high | +1720.8% |
Health Catalyst Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $328.33 M(+62.6%) |
| June 2024 | - | $201.90 M(+0.3%) |
| Mar 2024 | - | $201.37 M(+89.5%) |
| Dec 2023 | $106.28 M(-8.6%) | $106.28 M(+11.9%) |
| Sept 2023 | - | $94.97 M(-17.9%) |
| June 2023 | - | $115.69 M(-13.3%) |
| Mar 2023 | - | $133.48 M(+14.8%) |
| Dec 2022 | $116.31 M(-39.8%) | $116.31 M(-6.4%) |
| Sept 2022 | - | $124.22 M(-29.8%) |
| June 2022 | - | $176.98 M(-10.8%) |
| Mar 2022 | - | $198.43 M(+2.7%) |
| Dec 2021 | $193.23 M | $193.23 M(-29.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $275.76 M(+34.5%) |
| June 2021 | - | $205.09 M(+54.6%) |
| Mar 2021 | - | $132.63 M(+44.2%) |
| Dec 2020 | $91.95 M(+409.9%) | $91.95 M(-17.3%) |
| Sept 2020 | - | $111.24 M(+6.8%) |
| June 2020 | - | $104.19 M(+70.9%) |
| Mar 2020 | - | $60.97 M(+238.1%) |
| Dec 2019 | $18.03 M(-36.6%) | $18.03 M(-65.4%) |
| Sept 2019 | - | $52.06 M(+150.1%) |
| June 2019 | - | $20.82 M(-35.4%) |
| Mar 2019 | - | $32.21 M(+13.3%) |
| Dec 2018 | $28.43 M(+23.7%) | $28.43 M |
| Dec 2017 | $22.98 M | - |
FAQ
- What is Health Catalyst annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Health Catalyst?
- What is Health Catalyst annual cash & cash equivalents year-on-year change?
- What is Health Catalyst quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Health Catalyst?
- What is Health Catalyst quarterly cash and cash equivalents year-on-year change?
What is Health Catalyst annual cash & cash equivalents?
The current annual cash & cash equivalents of HCAT is $106.28 M
What is the all time high annual cash & cash equivalents for Health Catalyst?
Health Catalyst all-time high annual cash & cash equivalents is $193.23 M
What is Health Catalyst annual cash & cash equivalents year-on-year change?
Over the past year, HCAT annual cash & cash equivalents has changed by -$10.04 M (-8.63%)
What is Health Catalyst quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HCAT is $328.33 M
What is the all time high quarterly cash and cash equivalents for Health Catalyst?
Health Catalyst all-time high quarterly cash and cash equivalents is $328.33 M
What is Health Catalyst quarterly cash and cash equivalents year-on-year change?
Over the past year, HCAT quarterly cash and cash equivalents has changed by +$233.36 M (+245.71%)